Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Maarouf

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Neuroimage. Clinical|March 21, 2021
Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosisJan-Patrick Stellmann, Nadine Wanke, Adil Maarouf, et al.
Plos One|April 3, 2014
Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learningAlessandro Crimi, Olivier Commowick, Adil Maarouf, et al.
Annals of Neurology|November 15, 2019
Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody DiseasesPierre Durozard, Audrey Rico, Clémence Boutiere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-upAnne Kerbrat, Benoit Combès, Olivier Commowick, et al.
Neurology|March 25, 2024
Anti-IgLON5 Disease With Inaugural Bilateral NeuropapillitisSarah Demortiere, Bastien Joubert, Marie Benaiteau, et al.
Brain Structure & Function|November 5, 2025
Early structural hub disruption leads to premature functional adaption in multiple sclerosisJan-Patrick Stellmann, Adil Maarouf, Mihaela Nicolescu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 8, 2024
Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosisAdil Maarouf, Jan Patrick Stellmann, Audrey Rico, et al.
European Journal of Neurology|March 27, 2024
Factors affecting the topography of nitrous oxide-induced neurological complicationsEva Sole Cruz, Etienne Fortanier, Frederic Hilezian, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2023
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?Roxane Claverie, Marine Perriguey, Audrey Rico, et al.
Scientific Reports|March 14, 2018
Distribution of brain sodium long and short relaxation times and concentrations: a multi-echo ultra-high field <sup>23</sup>Na MRI studyBen Ridley, Armin M Nagel, Mark Bydder, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Neuroimage. Clinical|March 21, 2021
Cognitive performance shows domain specific associations with regional cortical thickness in multiple sclerosisJan-Patrick Stellmann, Nadine Wanke, Adil Maarouf, et al.
Plos One|April 3, 2014
Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learningAlessandro Crimi, Olivier Commowick, Adil Maarouf, et al.
Annals of Neurology|November 15, 2019
Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody DiseasesPierre Durozard, Audrey Rico, Clémence Boutiere, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 25, 2017
USPIO-positive MS lesions are associated with greater tissue damage than gadolinium-positive-only lesions during 3-year follow-upAnne Kerbrat, Benoit Combès, Olivier Commowick, et al.
Neurology|March 25, 2024
Anti-IgLON5 Disease With Inaugural Bilateral NeuropapillitisSarah Demortiere, Bastien Joubert, Marie Benaiteau, et al.
Brain Structure & Function|November 5, 2025
Early structural hub disruption leads to premature functional adaption in multiple sclerosisJan-Patrick Stellmann, Adil Maarouf, Mihaela Nicolescu, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 8, 2024
Active and non-active progression independent of relapse activity within the first 20 years of relapsing multiple sclerosisAdil Maarouf, Jan Patrick Stellmann, Audrey Rico, et al.
European Journal of Neurology|March 27, 2024
Factors affecting the topography of nitrous oxide-induced neurological complicationsEva Sole Cruz, Etienne Fortanier, Frederic Hilezian, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2023
Efficacy of Rituximab Outlasts B-Cell Repopulation in Multiple Sclerosis: Time to Rethink Dosing?Roxane Claverie, Marine Perriguey, Audrey Rico, et al.
Scientific Reports|March 14, 2018
Distribution of brain sodium long and short relaxation times and concentrations: a multi-echo ultra-high field <sup>23</sup>Na MRI studyBen Ridley, Armin M Nagel, Mark Bydder, et al.
Pageof 6